0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Kidney Transplant Medicine Market Research Report 2025
Published Date: April 2025
|
Report Code: QYRE-Auto-37B12244
Home | Market Reports | Health| Medical Facilities & Services
Global Kidney Transplant Medicine Market Research Report 2022
BUY CHAPTERS

Global Kidney Transplant Medicine Market Research Report 2025

Code: QYRE-Auto-37B12244
Report
April 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Kidney Transplant Medicine Market Size

The global market for Kidney Transplant Medicine was valued at US$ 2034 million in the year 2024 and is projected to reach a revised size of US$ 3136 million by 2031, growing at a CAGR of 6.7% during the forecast period.

Kidney Transplant Medicine Market

Kidney Transplant Medicine Market

Kidney Transplant Medicine (Kidney Transplantation Drugs) refers to the group of medications prescribed to individuals who have undergone kidney transplantation. These medications are crucial for ensuring the success of the transplant, preventing organ rejection, and managing complications associated with the transplant procedure.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Kidney Transplant Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Kidney Transplant Medicine.
The Kidney Transplant Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Kidney Transplant Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Kidney Transplant Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Kidney Transplant Medicine Market Report

Report Metric Details
Report Name Kidney Transplant Medicine Market
Accounted market size in year US$ 2034 million
Forecasted market size in 2031 US$ 3136 million
CAGR 6.7%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Tacrolimus
  • Ciclosporin
  • Azathioprine
  • Mycophenolate
  • Other
Segment by Application
  • Online Sales
  • Offline Sales
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Hansa Biopharma, Pfizer, Prometheus Laboratories, Mayne Pharma Group Limited, Roche Pharmaceuticals, BHARAT SERUM, Sanofi, Astellas Pharma, GlaxoSmithKline plc, Novartis, Veloxis Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Kidney Transplant Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Kidney Transplant Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Kidney Transplant Medicine Market growing?

Ans: The Kidney Transplant Medicine Market witnessing a CAGR of 6.7% during the forecast period 2025-2031.

What is the Kidney Transplant Medicine Market size in 2031?

Ans: The Kidney Transplant Medicine Market size in 2031 will be US$ 3136 million.

Who are the main players in the Kidney Transplant Medicine Market report?

Ans: The main players in the Kidney Transplant Medicine Market are Hansa Biopharma, Pfizer, Prometheus Laboratories, Mayne Pharma Group Limited, Roche Pharmaceuticals, BHARAT SERUM, Sanofi, Astellas Pharma, GlaxoSmithKline plc, Novartis, Veloxis Pharmaceuticals

What are the Application segmentation covered in the Kidney Transplant Medicine Market report?

Ans: The Applications covered in the Kidney Transplant Medicine Market report are Online Sales, Offline Sales

What are the Type segmentation covered in the Kidney Transplant Medicine Market report?

Ans: The Types covered in the Kidney Transplant Medicine Market report are Tacrolimus, Ciclosporin, Azathioprine, Mycophenolate, Other

1 Kidney Transplant Medicine Market Overview
1.1 Product Definition
1.2 Kidney Transplant Medicine by Type
1.2.1 Global Kidney Transplant Medicine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Tacrolimus
1.2.3 Ciclosporin
1.2.4 Azathioprine
1.2.5 Mycophenolate
1.2.6 Other
1.3 Kidney Transplant Medicine by Application
1.3.1 Global Kidney Transplant Medicine Market Value by Application (2024 VS 2031)
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Global Kidney Transplant Medicine Market Size Estimates and Forecasts
1.4.1 Global Kidney Transplant Medicine Revenue 2020-2031
1.4.2 Global Kidney Transplant Medicine Sales 2020-2031
1.4.3 Global Kidney Transplant Medicine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Kidney Transplant Medicine Market Competition by Manufacturers
2.1 Global Kidney Transplant Medicine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Kidney Transplant Medicine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Kidney Transplant Medicine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Kidney Transplant Medicine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Kidney Transplant Medicine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Kidney Transplant Medicine, Product Type & Application
2.7 Global Key Manufacturers of Kidney Transplant Medicine, Date of Enter into This Industry
2.8 Global Kidney Transplant Medicine Market Competitive Situation and Trends
2.8.1 Global Kidney Transplant Medicine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Kidney Transplant Medicine Players Market Share by Revenue
2.8.3 Global Kidney Transplant Medicine Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Kidney Transplant Medicine Market Scenario by Region
3.1 Global Kidney Transplant Medicine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Kidney Transplant Medicine Sales by Region: 2020-2031
3.2.1 Global Kidney Transplant Medicine Sales by Region: 2020-2025
3.2.2 Global Kidney Transplant Medicine Sales by Region: 2026-2031
3.3 Global Kidney Transplant Medicine Revenue by Region: 2020-2031
3.3.1 Global Kidney Transplant Medicine Revenue by Region: 2020-2025
3.3.2 Global Kidney Transplant Medicine Revenue by Region: 2026-2031
3.4 North America Kidney Transplant Medicine Market Facts & Figures by Country
3.4.1 North America Kidney Transplant Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Kidney Transplant Medicine Sales by Country (2020-2031)
3.4.3 North America Kidney Transplant Medicine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Kidney Transplant Medicine Market Facts & Figures by Country
3.5.1 Europe Kidney Transplant Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Kidney Transplant Medicine Sales by Country (2020-2031)
3.5.3 Europe Kidney Transplant Medicine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Kidney Transplant Medicine Market Facts & Figures by Region
3.6.1 Asia Pacific Kidney Transplant Medicine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Kidney Transplant Medicine Sales by Region (2020-2031)
3.6.3 Asia Pacific Kidney Transplant Medicine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Kidney Transplant Medicine Market Facts & Figures by Country
3.7.1 Latin America Kidney Transplant Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Kidney Transplant Medicine Sales by Country (2020-2031)
3.7.3 Latin America Kidney Transplant Medicine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Kidney Transplant Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa Kidney Transplant Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Kidney Transplant Medicine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Kidney Transplant Medicine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Kidney Transplant Medicine Sales by Type (2020-2031)
4.1.1 Global Kidney Transplant Medicine Sales by Type (2020-2025)
4.1.2 Global Kidney Transplant Medicine Sales by Type (2026-2031)
4.1.3 Global Kidney Transplant Medicine Sales Market Share by Type (2020-2031)
4.2 Global Kidney Transplant Medicine Revenue by Type (2020-2031)
4.2.1 Global Kidney Transplant Medicine Revenue by Type (2020-2025)
4.2.2 Global Kidney Transplant Medicine Revenue by Type (2026-2031)
4.2.3 Global Kidney Transplant Medicine Revenue Market Share by Type (2020-2031)
4.3 Global Kidney Transplant Medicine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Kidney Transplant Medicine Sales by Application (2020-2031)
5.1.1 Global Kidney Transplant Medicine Sales by Application (2020-2025)
5.1.2 Global Kidney Transplant Medicine Sales by Application (2026-2031)
5.1.3 Global Kidney Transplant Medicine Sales Market Share by Application (2020-2031)
5.2 Global Kidney Transplant Medicine Revenue by Application (2020-2031)
5.2.1 Global Kidney Transplant Medicine Revenue by Application (2020-2025)
5.2.2 Global Kidney Transplant Medicine Revenue by Application (2026-2031)
5.2.3 Global Kidney Transplant Medicine Revenue Market Share by Application (2020-2031)
5.3 Global Kidney Transplant Medicine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Hansa Biopharma
6.1.1 Hansa Biopharma Company Information
6.1.2 Hansa Biopharma Description and Business Overview
6.1.3 Hansa Biopharma Kidney Transplant Medicine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Hansa Biopharma Kidney Transplant Medicine Product Portfolio
6.1.5 Hansa Biopharma Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Kidney Transplant Medicine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer Kidney Transplant Medicine Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Prometheus Laboratories
6.3.1 Prometheus Laboratories Company Information
6.3.2 Prometheus Laboratories Description and Business Overview
6.3.3 Prometheus Laboratories Kidney Transplant Medicine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Prometheus Laboratories Kidney Transplant Medicine Product Portfolio
6.3.5 Prometheus Laboratories Recent Developments/Updates
6.4 Mayne Pharma Group Limited
6.4.1 Mayne Pharma Group Limited Company Information
6.4.2 Mayne Pharma Group Limited Description and Business Overview
6.4.3 Mayne Pharma Group Limited Kidney Transplant Medicine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Mayne Pharma Group Limited Kidney Transplant Medicine Product Portfolio
6.4.5 Mayne Pharma Group Limited Recent Developments/Updates
6.5 Roche Pharmaceuticals
6.5.1 Roche Pharmaceuticals Company Information
6.5.2 Roche Pharmaceuticals Description and Business Overview
6.5.3 Roche Pharmaceuticals Kidney Transplant Medicine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Roche Pharmaceuticals Kidney Transplant Medicine Product Portfolio
6.5.5 Roche Pharmaceuticals Recent Developments/Updates
6.6 BHARAT SERUM
6.6.1 BHARAT SERUM Company Information
6.6.2 BHARAT SERUM Description and Business Overview
6.6.3 BHARAT SERUM Kidney Transplant Medicine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 BHARAT SERUM Kidney Transplant Medicine Product Portfolio
6.6.5 BHARAT SERUM Recent Developments/Updates
6.7 Sanofi
6.7.1 Sanofi Company Information
6.7.2 Sanofi Description and Business Overview
6.7.3 Sanofi Kidney Transplant Medicine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sanofi Kidney Transplant Medicine Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 Astellas Pharma
6.8.1 Astellas Pharma Company Information
6.8.2 Astellas Pharma Description and Business Overview
6.8.3 Astellas Pharma Kidney Transplant Medicine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Astellas Pharma Kidney Transplant Medicine Product Portfolio
6.8.5 Astellas Pharma Recent Developments/Updates
6.9 GlaxoSmithKline plc
6.9.1 GlaxoSmithKline plc Company Information
6.9.2 GlaxoSmithKline plc Description and Business Overview
6.9.3 GlaxoSmithKline plc Kidney Transplant Medicine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 GlaxoSmithKline plc Kidney Transplant Medicine Product Portfolio
6.9.5 GlaxoSmithKline plc Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Company Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Kidney Transplant Medicine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Novartis Kidney Transplant Medicine Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 Veloxis Pharmaceuticals
6.11.1 Veloxis Pharmaceuticals Company Information
6.11.2 Veloxis Pharmaceuticals Description and Business Overview
6.11.3 Veloxis Pharmaceuticals Kidney Transplant Medicine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Veloxis Pharmaceuticals Kidney Transplant Medicine Product Portfolio
6.11.5 Veloxis Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Kidney Transplant Medicine Industry Chain Analysis
7.2 Kidney Transplant Medicine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Kidney Transplant Medicine Production Mode & Process Analysis
7.4 Kidney Transplant Medicine Sales and Marketing
7.4.1 Kidney Transplant Medicine Sales Channels
7.4.2 Kidney Transplant Medicine Distributors
7.5 Kidney Transplant Medicine Customer Analysis
8 Kidney Transplant Medicine Market Dynamics
8.1 Kidney Transplant Medicine Industry Trends
8.2 Kidney Transplant Medicine Market Drivers
8.3 Kidney Transplant Medicine Market Challenges
8.4 Kidney Transplant Medicine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Kidney Transplant Medicine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Kidney Transplant Medicine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Kidney Transplant Medicine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Kidney Transplant Medicine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Kidney Transplant Medicine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Kidney Transplant Medicine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Kidney Transplant Medicine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Kidney Transplant Medicine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Kidney Transplant Medicine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Kidney Transplant Medicine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Kidney Transplant Medicine, Product Type & Application
 Table 12. Global Key Manufacturers of Kidney Transplant Medicine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Kidney Transplant Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Transplant Medicine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Kidney Transplant Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Kidney Transplant Medicine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Kidney Transplant Medicine Sales Market Share by Region (2020-2025)
 Table 19. Global Kidney Transplant Medicine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Kidney Transplant Medicine Sales Market Share by Region (2026-2031)
 Table 21. Global Kidney Transplant Medicine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Kidney Transplant Medicine Revenue Market Share by Region (2020-2025)
 Table 23. Global Kidney Transplant Medicine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Kidney Transplant Medicine Revenue Market Share by Region (2026-2031)
 Table 25. North America Kidney Transplant Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Kidney Transplant Medicine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Kidney Transplant Medicine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Kidney Transplant Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Kidney Transplant Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Kidney Transplant Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Kidney Transplant Medicine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Kidney Transplant Medicine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Kidney Transplant Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Kidney Transplant Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Kidney Transplant Medicine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Kidney Transplant Medicine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Kidney Transplant Medicine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Kidney Transplant Medicine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Kidney Transplant Medicine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Kidney Transplant Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Kidney Transplant Medicine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Kidney Transplant Medicine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Kidney Transplant Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Kidney Transplant Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Kidney Transplant Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Kidney Transplant Medicine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Kidney Transplant Medicine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Kidney Transplant Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Kidney Transplant Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Kidney Transplant Medicine Sales (K Units) by Type (2020-2025)
 Table 51. Global Kidney Transplant Medicine Sales (K Units) by Type (2026-2031)
 Table 52. Global Kidney Transplant Medicine Sales Market Share by Type (2020-2025)
 Table 53. Global Kidney Transplant Medicine Sales Market Share by Type (2026-2031)
 Table 54. Global Kidney Transplant Medicine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Kidney Transplant Medicine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Kidney Transplant Medicine Revenue Market Share by Type (2020-2025)
 Table 57. Global Kidney Transplant Medicine Revenue Market Share by Type (2026-2031)
 Table 58. Global Kidney Transplant Medicine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Kidney Transplant Medicine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Kidney Transplant Medicine Sales (K Units) by Application (2020-2025)
 Table 61. Global Kidney Transplant Medicine Sales (K Units) by Application (2026-2031)
 Table 62. Global Kidney Transplant Medicine Sales Market Share by Application (2020-2025)
 Table 63. Global Kidney Transplant Medicine Sales Market Share by Application (2026-2031)
 Table 64. Global Kidney Transplant Medicine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Kidney Transplant Medicine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Kidney Transplant Medicine Revenue Market Share by Application (2020-2025)
 Table 67. Global Kidney Transplant Medicine Revenue Market Share by Application (2026-2031)
 Table 68. Global Kidney Transplant Medicine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Kidney Transplant Medicine Price (US$/Unit) by Application (2026-2031)
 Table 70. Hansa Biopharma Company Information
 Table 71. Hansa Biopharma Description and Business Overview
 Table 72. Hansa Biopharma Kidney Transplant Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Hansa Biopharma Kidney Transplant Medicine Product
 Table 74. Hansa Biopharma Recent Developments/Updates
 Table 75. Pfizer Company Information
 Table 76. Pfizer Description and Business Overview
 Table 77. Pfizer Kidney Transplant Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Pfizer Kidney Transplant Medicine Product
 Table 79. Pfizer Recent Developments/Updates
 Table 80. Prometheus Laboratories Company Information
 Table 81. Prometheus Laboratories Description and Business Overview
 Table 82. Prometheus Laboratories Kidney Transplant Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Prometheus Laboratories Kidney Transplant Medicine Product
 Table 84. Prometheus Laboratories Recent Developments/Updates
 Table 85. Mayne Pharma Group Limited Company Information
 Table 86. Mayne Pharma Group Limited Description and Business Overview
 Table 87. Mayne Pharma Group Limited Kidney Transplant Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Mayne Pharma Group Limited Kidney Transplant Medicine Product
 Table 89. Mayne Pharma Group Limited Recent Developments/Updates
 Table 90. Roche Pharmaceuticals Company Information
 Table 91. Roche Pharmaceuticals Description and Business Overview
 Table 92. Roche Pharmaceuticals Kidney Transplant Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Roche Pharmaceuticals Kidney Transplant Medicine Product
 Table 94. Roche Pharmaceuticals Recent Developments/Updates
 Table 95. BHARAT SERUM Company Information
 Table 96. BHARAT SERUM Description and Business Overview
 Table 97. BHARAT SERUM Kidney Transplant Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. BHARAT SERUM Kidney Transplant Medicine Product
 Table 99. BHARAT SERUM Recent Developments/Updates
 Table 100. Sanofi Company Information
 Table 101. Sanofi Description and Business Overview
 Table 102. Sanofi Kidney Transplant Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Sanofi Kidney Transplant Medicine Product
 Table 104. Sanofi Recent Developments/Updates
 Table 105. Astellas Pharma Company Information
 Table 106. Astellas Pharma Description and Business Overview
 Table 107. Astellas Pharma Kidney Transplant Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Astellas Pharma Kidney Transplant Medicine Product
 Table 109. Astellas Pharma Recent Developments/Updates
 Table 110. GlaxoSmithKline plc Company Information
 Table 111. GlaxoSmithKline plc Description and Business Overview
 Table 112. GlaxoSmithKline plc Kidney Transplant Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. GlaxoSmithKline plc Kidney Transplant Medicine Product
 Table 114. GlaxoSmithKline plc Recent Developments/Updates
 Table 115. Novartis Company Information
 Table 116. Novartis Description and Business Overview
 Table 117. Novartis Kidney Transplant Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Novartis Kidney Transplant Medicine Product
 Table 119. Novartis Recent Developments/Updates
 Table 120. Veloxis Pharmaceuticals Company Information
 Table 121. Veloxis Pharmaceuticals Description and Business Overview
 Table 122. Veloxis Pharmaceuticals Kidney Transplant Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Veloxis Pharmaceuticals Kidney Transplant Medicine Product
 Table 124. Veloxis Pharmaceuticals Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Kidney Transplant Medicine Distributors List
 Table 128. Kidney Transplant Medicine Customers List
 Table 129. Kidney Transplant Medicine Market Trends
 Table 130. Kidney Transplant Medicine Market Drivers
 Table 131. Kidney Transplant Medicine Market Challenges
 Table 132. Kidney Transplant Medicine Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Kidney Transplant Medicine
 Figure 2. Global Kidney Transplant Medicine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Kidney Transplant Medicine Market Share by Type: 2024 & 2031
 Figure 4. Tacrolimus Product Picture
 Figure 5. Ciclosporin Product Picture
 Figure 6. Azathioprine Product Picture
 Figure 7. Mycophenolate Product Picture
 Figure 8. Other Product Picture
 Figure 9. Global Kidney Transplant Medicine Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Kidney Transplant Medicine Market Share by Application: 2024 & 2031
 Figure 11. Online Sales
 Figure 12. Offline Sales
 Figure 13. Global Kidney Transplant Medicine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Kidney Transplant Medicine Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Kidney Transplant Medicine Sales (2020-2031) & (K Units)
 Figure 16. Global Kidney Transplant Medicine Average Price (US$/Unit) & (2020-2031)
 Figure 17. Kidney Transplant Medicine Report Years Considered
 Figure 18. Kidney Transplant Medicine Sales Share by Manufacturers in 2024
 Figure 19. Global Kidney Transplant Medicine Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Kidney Transplant Medicine Players: Market Share by Revenue in Kidney Transplant Medicine in 2024
 Figure 21. Kidney Transplant Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Kidney Transplant Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Kidney Transplant Medicine Sales Market Share by Country (2020-2031)
 Figure 24. North America Kidney Transplant Medicine Revenue Market Share by Country (2020-2031)
 Figure 25. United States Kidney Transplant Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Kidney Transplant Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Kidney Transplant Medicine Sales Market Share by Country (2020-2031)
 Figure 28. Europe Kidney Transplant Medicine Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Kidney Transplant Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Kidney Transplant Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Kidney Transplant Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Kidney Transplant Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Kidney Transplant Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Kidney Transplant Medicine Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Kidney Transplant Medicine Revenue Market Share by Region (2020-2031)
 Figure 36. China Kidney Transplant Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Kidney Transplant Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Kidney Transplant Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Kidney Transplant Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Kidney Transplant Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Kidney Transplant Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Kidney Transplant Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Kidney Transplant Medicine Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Kidney Transplant Medicine Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Kidney Transplant Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Kidney Transplant Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Kidney Transplant Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Kidney Transplant Medicine Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Kidney Transplant Medicine Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Kidney Transplant Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Kidney Transplant Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Kidney Transplant Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Kidney Transplant Medicine by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Kidney Transplant Medicine by Type (2020-2031)
 Figure 55. Global Kidney Transplant Medicine Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Kidney Transplant Medicine by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Kidney Transplant Medicine by Application (2020-2031)
 Figure 58. Global Kidney Transplant Medicine Price (US$/Unit) by Application (2020-2031)
 Figure 59. Kidney Transplant Medicine Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

RELATED REPORTS

Global Spinal Needle for Surgery Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37D12504
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Kidney Disease Management Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30D17962
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Digital Platform for Renal Care Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-39G18133
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global AI-powered Care Coordination Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4N20277
Fri Nov 28 00:00:00 UTC 2025

Add to Cart